載入...
Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging
One of the most clinically relevant molecular aberrations in breast cancer is overexpression of human epidermal growth factor receptor type 2 (HER2). We aimed to develop a radiolabeled tyrosine kinase inhibitor for HER2-targeted breast cancer imaging. In this study, a radioiodinated analog ((125/131...
Na minha lista:
| 發表在: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Society of Nuclear Medicine
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6126446/ https://ncbi.nlm.nih.gov/pubmed/29653973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.205088 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|